Please login to the form below

Not currently logged in
Email:
Password:

Harren Jhoti and Will West join BIA board

UK biotech trade body welcomes CEOs of Astex Pharmaceuticals and CellCentric

The UK's BioIndustry Association (BIA) has appointed Harren Jhoti, CEO of Astex Pharmaceuticals, and Will West, CEO of CellCentric, to its board of directors.

They take over from Andrew Heath, managing director of Morvus, and Dominique Kleyn, CEO of London Genetics, who will stand down at the end of 2012.

The BIA, which represents the country's bioscience industry, also re-appointed Allan Marchington, partner at Apposite Capital, to the board.

All appointments will serve from January 1, 2013, for a term of two years.

Tim Edwards, BIA chairman, said: “As a result of these appointments, I believe our board continues to broaden its outlook and experience, and I look forward to working with them and the BIA team to ensure the UK remains a world-leading location for the life sciences.”

10th October 2012

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...